LncCeRBase

Welcome to the LncCeRBase DataBase!
LncRNA MiRNA Gene Gene name Pathway Name Description Title Disease/Tissue Journal PubMed ID
H19 miR-138 ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
Furthermore, by using bioinformatics study and RNA immunoprecipitation combined with luciferase reporter assays, we demonstrated that H19 functioned as a competing endogenous RNA (ceRNA) for miR-138 and miR-200a, antagonized their functions and led to the de-repression of their endogenous targets Vimentin, ZEB1, and ZEB2, all of which were core marker genes for mesenchymal cells.
details
The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer
Colorectal Cancer Oncotarget 26068968
UCA1 miR-145 ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
Mechanistically, lncRNA-UCA1 induced EMT of bladder cancer cells by upregulating the expression levels of zinc finger E-box binding homeobox 1 and 2 (ZEB1 and ZEB2), and regulated bladder cancer cell migration and invasion by tumor suppressive hsa-miR-145 and its target gene the actin-binding protein fascin homologue 1 (FSCN1).
details
Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN2 pathway
Bladder Cancer Cancer Sci 26544536
H19 miR-200a ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
Furthermore, we showed that H19 promotes metastasis through upregulation of ZEB1 and ZEB2 by competitively binding the miR-200 family.
details
H19 Functions as a ceRNA in Promoting Metastasis Through Decreasing miR-200s Activity in Osteosarcoma
Osteosarcoma DNA Cell Biol 27008415
H19 miR-200a ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
Furthermore, by using bioinformatics study and RNA immunoprecipitation combined with luciferase reporter assays, we demonstrated that H19 functioned as a competing endogenous RNA (ceRNA) for miR-138 and miR-200a, antagonized their functions and led to the de-repression of their endogenous targets Vimentin, ZEB1, and ZEB2, all of which were core marker genes for mesenchymal cells.
details
The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer
Colorectal Cancer Oncotarget 26068968
MALAT1 miR-200a ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
We further demonstrated MALAT1 promote KIRC proliferation and metastasis through sponging miR-200s in vitro and in vivo. In addition, miR-200c can partly reverse the MALAT1's stimulation on proliferation and metastasis in KIRC. In summary we unveil a branch of the MALAT1/miR-200s/ZEB2 pathway that regulates the progression of KIRC.
details
LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma
Kidney Carcinoma Oncotarget 26461224
H19 miR-200b ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
Furthermore, we showed that H19 promotes metastasis through upregulation of ZEB1 and ZEB2 by competitively binding the miR-200 family.
details
H19 Functions as a ceRNA in Promoting Metastasis Through Decreasing miR-200s Activity in Osteosarcoma
Osteosarcoma DNA Cell Biol 27008415
MALAT1 miR-200b ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
We further demonstrated MALAT1 promote KIRC proliferation and metastasis through sponging miR-200s in vitro and in vivo. In addition, miR-200c can partly reverse the MALAT1's stimulation on proliferation and metastasis in KIRC. In summary we unveil a branch of the MALAT1/miR-200s/ZEB2 pathway that regulates the progression of KIRC.
details
LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma
Kidney Carcinoma Oncotarget 26461224
H19 miR-200c ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
Furthermore, we showed that H19 promotes metastasis through upregulation of ZEB1 and ZEB2 by competitively binding the miR-200 family.
details
H19 Functions as a ceRNA in Promoting Metastasis Through Decreasing miR-200s Activity in Osteosarcoma
Osteosarcoma DNA Cell Biol 27008415
MALAT1 miR-200c ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
We further demonstrated MALAT1 promote KIRC proliferation and metastasis through sponging miR-200s in vitro and in vivo. In addition, miR-200c can partly reverse the MALAT1's stimulation on proliferation and metastasis in KIRC. In summary we unveil a branch of the MALAT1/miR-200s/ZEB2 pathway that regulates the progression of KIRC.
details
LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma
Kidney Carcinoma Oncotarget 26461224
H19 miR-200s ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
Furthermore, we showed that H19 promotes metastasis through upregulation of ZEB1 and ZEB2 by competitively binding the miR-200 family.
details
H19 Functions as a ceRNA in Promoting Metastasis Through Decreasing miR-200s Activity in Osteosarcoma
Osteosarcoma DNA Cell Biol 27008415
ROR miR-205 ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
Specifically, linc-ROR prevented the degradation of mir-205 target genes, including the EMT inducer ZEB2.
details
LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis
Breast Cancer Cell Death Dis 24922071
ROR miR-205 ZEB2 ZEB2;HSPC082;SIP-1;SIP1;SMADIP1;ZFHX1B details
details
Compared with the MCF7 cells, the MCF7-ROR cells had remarkably higher proliferation rates, down-regulated E-cadherin and miR-205 expressions, as well as increased vimentin, invasive ability, and mRNA expression of ZEB1 and ZEB2. Compared with the MCF7/TR5 and MDA-MB-231 cells, up-regulated E-cadherin and miR-205 expression, down-regulated expression of vimentin, ZEB1, and ZEB2 mRNA, and decreased invasive ability were observed in the MCF7/TR5 ROR-siRNA and MDA-MB-231 ROR-siRNA cells.
details
Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205
Breast Cancer Cancer Chemother Pharmacol 28063065